WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2005061006) PRODRUG OF ANTICHOLINERGIC AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/061006 International Application No.: PCT/JP2004/019193
Publication Date: 07.07.2005 International Filing Date: 22.12.2004
IPC:
A61K 31/46 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
46
8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
Applicants: YAMASHITA, Shinya[JP/JP]; JP (UsOnly)
TAKEO, Jiro[JP/JP]; JP (UsOnly)
OKITA, Takaaki[JP/JP]; JP (UsOnly)
NIPPON SUISAN KAISHA, LTD.[JP/JP]; 6-2, Otemachi 2-chome Chiyoda-ku, Tokyo 1008686, JP (AllExceptUS)
Inventors: YAMASHITA, Shinya; JP
TAKEO, Jiro; JP
OKITA, Takaaki; JP
Priority Data:
2003-42668624.12.2003JP
Title (EN) PRODRUG OF ANTICHOLINERGIC AGENT
(FR) PROMEDICAMENT D'AGENT ANTICHOLINERGIQUE
(JA) 抗コリン薬のプロドラッグ
Abstract:
(EN) It is intended to provide a prodrug of an anticholinergic agent aiming at lessening a side effect of the anticholinergic agent. Namely, a prodrug produced by attaching a substituent, which is excised by an enzyme showing a difference in its activity between a target site wherein the main effect is to be established and a site wherein the side effect is to be established, to an anticholinergic agent.
(FR) Cette invention concerne un promédicament d'agent anticholinergique destiné à atténuer les effets secondaire dudit agent. Ce promédicament s'obtient en rattachant à un agent anticholinergique un substituant excis par une enzyme qui présente une différence d'activité entre un site cible sur lequel son effet principal doit être déterminé et un autre site sur lequel l'effet secondaire doit être déterminé
(JA) not available
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)